India  

Balram Bhargava

Indian science administrator

Balram Bhargava    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Balram Bhargava is an Indian science administrator. He has been appointed for a three-year tenure as the Director-General at the Indian Council of Medical Research, New Delhi and Secretary, Department of Health Research a division under Ministry of Health and Family Welfare, Government of India.

0
shares
ShareTweetSavePostSend
 

‘No difference in Covid death percentage between first & second wave’: ICMR D-G [Video]

‘No difference in Covid death percentage between first & second wave’: ICMR D-G

Dr Balram Bhargava, Director-General (DG) of the Indian Council of Medical Research (ICMR) said there is no change in death rate between the first and second Covid-19 wave. "There is no change in the..

Credit: HT Digital Content     Duration: 01:57Published
No difference in death percentage between 1st and 2nd COVID wave: ICMR DG [Video]

No difference in death percentage between 1st and 2nd COVID wave: ICMR DG

Indian Council of Medical Research (ICMR) Chief, Dr. Balram Bhargava on April 19 said that in the second wave of COVID, there is no difference found in the percentage of death in comparison to 1st wave..

Credit: ANI     Duration: 01:03Published
Covid: Centre explains 5 steps discussed with States to curb virus spread [Video]

Covid: Centre explains 5 steps discussed with States to curb virus spread

Centre on Saturday spoke on the five steps discussed with the States that have high number of Covid-19 cases. Health Secretary Rajesh Bhushan said that Centre discussed the steps with States to curb..

Credit: HT Digital Content     Duration: 09:52Published

You Might Like


Only 2-4 infections per 10k found in those vaccinated with two doses: ICMR

In a strong validation of the utility of vaccines in combating Covid 19, the Indian Council of Medical Research (ICMR) on Wednesday said only 2-4 per 10,000 “breakthrough” infections were noted in..
IndiaTimes - Published

Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chief

Covid-19 vaccines reduce the chances of developing severe infection and mortality, ICMR chief Balram Bhargava said on Tuesday.
IndiaTimes - Published

Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: Govt

Both Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre..
IndiaTimes - Published

South Africa, Brazil mutated Covid strains have reached India

The South African and Brazilian mutant strains of coronavirus have entered the country, apart from the UK variant reported in 187 people so far. Four persons were detected with the South Africa variant..
IndiaTimes - Published

Those on blood thinners can receive vaccine, says ICMR

Fact-sheets of both Covaxin and Covishield will be revised soon so that people on blood thinners like aspirin and clopidogrel can receive the vaccines, while those on anticoagulants may also take the..
IndiaTimes - Published

No irregularity in approval to Covaxin: ICMR

In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
IndiaTimes - Published

Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief

The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and..
IndiaTimes - Published

ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19

This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day.
DNA - Published

ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma Centre

Indian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a..
IndiaTimes - Published

‘Adverse event’ won’t affect vaccine rollout plan: Government

ICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or..
IndiaTimes - Published

‘No vaccine for respiratory diseases has 100% efficacy’

No vaccine for respiratory diseases has a 100% efficacy and ones with a 50-100% efficacy may be approved for use against the Covid-19 pandemic, Indian Council for Medical Research (ICMR) director..
IndiaTimes - Published

Govt asks states to upload rapid antigen testing data on ICMR portal

In a letter to all states and union territories Indian Council for Medical Research director general Balram Bhargava has said that with the use of rapid antigen tests, more and more tests are being..
IndiaTimes - Published

Two indigenous Indian vaccines cleared to start human trials, each has 1,000 volunteers

India is perceived and is an important player in the global vaccine supply, fast-tracking COVID-19 vaccine development is a moral duty, ICMR chief Balram Bhargava said.
DNA - Published

No vaccine before 2021, science minister says in release, deletes it

A fresh controversy erupted over India’s Covid-19 vaccine timelines with a department of science and technology (DST) press release first mentioning and then deleting a reference to the antidote..
IndiaTimes - Published

India is not in community transmission: ICMR

There is no community transmission of Covid-19 in the country according to the Indian Council of Medical Research (ICMR) on Thursday. Professor (Dr) Balram Bhargava, DG, ICMR, at a press conference in..
IndiaTimes - Published

'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatment

Responding to a query on the efficacy of hydroxychloroquine during a media briefing on COVID-19, ICMR chief Balram Bhargava said biological plausibility of HCQ was supporting that it might be an..
DNA - Published

Centre asks states to set up exclusive facilities for treating covid-19 patients

Addressing reporters on the preparedness of the government for prevention and containment of the disease, health ministry officials said the country has the capacity for conducting around 60,000-70,000..
IndiaTimes - Published

72 functional labs for coronavirus testing, private players to be engaged soon: ICMR

Private NABL-accredited labs will soon be operationalised across the country, ICMR chief Balram Bhargava said.
DNA - Published